Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Opko Health Inc
(NQ:
OPK
)
1.655
+0.005 (+0.30%)
Streaming Delayed Price
Updated: 11:51 AM EDT, Aug 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Opko Health Inc
< Previous
1
2
3
4
5
Next >
Bulls Find Silver Lining Into the Close
December 20, 2021
While it isn't exactly a ringing endorsement that the market is heading higher, it is an indication that the Grinch hasn't entirely spoiled the fun.
Via
Talk Markets
63 Biggest Movers From Friday
December 20, 2021
Gainers Spruce Biosciences, Inc. (NASDAQ: SPRB) jumped 102.8% to close at $5.03 on Friday after Oppenheimer initiated coverage on the stock with an Outperform rating and a $15...
Via
Benzinga
Earnings Scheduled For October 28, 2021
October 28, 2021
Companies Reporting Before The Bell • LendingTree (NASDAQ:TREE) is estimated to report quarterly earnings at $0.57 per share on revenue of $292.63 million. •...
Via
Benzinga
Earnings Scheduled For July 29, 2021
July 29, 2021
Companies Reporting Before The Bell • Smith & Nephew (NYSE:SNN) is projected to report earnings for its second quarter. • Cohen & Co (AMEX:COHN) is...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
December 17, 2021
Gainers Genfit (NASDAQ:GN...
Via
Benzinga
28 Stocks Moving In Friday's Mid-Day Session
December 17, 2021
Gainers Genfit SA (NASDAQ: GNFT) shares jumped 33.6% to $4.41 after the company, and Ipsen, announced an exclusive licensing agreement for elafibranor. X4 Pharmaceuticals, Inc...
Via
Benzinga
OPKO Health Q3 Earnings Ahead Of Expectations
October 29, 2021
OPKO Health Inc (NASDAQ: OPK) reported Q3 revenues were down 10% Y/Y to $385.8 million, beating the consensus of $302.27 million. Revenue from diagnostic services...
Via
Benzinga
Opko Health (OPK) Q3 2021 Earnings Call Transcript
October 29, 2021
OPK earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
12 Health Care Stocks Moving In Thursday's After-Market Session
October 28, 2021
Gainers Bellerophon Therapeutics (NASDAQ:
Via
Benzinga
This Growth Hormone Drug Could Be a Boost For Pfizer
October 05, 2021
Pfizer and OPKO Health's human growth hormone drug, somatrogon, could be approved by the U.S. Food and Drug Administration next January.
Via
The Motley Fool
Exposures
Product Safety
Pfizer's Growth Hormone Candidate FDA Review Pushed By 3 Months
September 27, 2021
Pfizer Inc's (NYSE: PFE) effort to defend its growth hormone franchise against a new, more convenient competitor has hit a snag. The FDA has pushed back...
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Friday's After-Market Session
September 24, 2021
Gainers eFFECTOR Therapeutics (NASDAQ:
Via
Benzinga
The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical
August 31, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)...
Via
Benzinga
Why Opko Health Shares Shriveled by Nearly 8% on Friday
July 30, 2021
The coronavirus stock didn't impress with its Q2 results.
Via
The Motley Fool
Exposures
COVID-19
Opko Health (OPK) Q2 2021 Earnings Call Transcript
July 30, 2021
OPK earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs
July 29, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
Product Safety
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
July 25, 2021
Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start...
Via
Benzinga
Exposures
Product Safety
Why Bionano Genomics, Invitae, and Opko Health Stocks Sank This Week
July 16, 2021
The market's pessimism about these diagnostics stocks appeared unrelated to company-specific news.
Via
The Motley Fool
Analyzing OPKO Health's Unusual Options Activity
July 15, 2021
OPKO Health (NASDAQ:OPK) shares experienced unusual options activity on Thursday. The stock price moved up to $3.56 following the option alert. Sentiment: BULLISH Option Type:...
Via
Benzinga
OPKO Health, CAMP4 Therapeutics Ink Oligonucleotide Platform With Focus On Drug-Resistant Epilepsy
July 12, 2021
OPKO Health Inc (NASDAQ: OPK) has entered into an exclusive worldwide agreement with privately-held CAMP4 Therapeutics Corporation (CAMP4) to develop,...
Via
Benzinga
OPKO Health, Nicoya Therapeutics Ink Rayaldee Pact For Hyperparathyroidism In Greater China
June 21, 2021
OPKO Health Inc's (NASDAQ: OPK) subsidiary EirGen Pharma has agreed to develop and commercialize Rayaldee to treat secondary hyperparathyroidism in...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 21, 2021
June 21, 2021
Upgrades B of A Securities upgraded the previous rating for Cimarex Energy Co (NYSE:
Via
Benzinga
OPKO Health Offloads Fill and Finish Manufacturing Facility in Ireland To Horizon Therapeutics
June 17, 2021
OPKO Health Inc's (NASDAQ: OPK) subsidiary, EirGen Pharma Ltd, has agreed to sell one of its facilities in Waterford, Ireland, to Horizon Therapeutics plc...
Via
Benzinga
Cramer Shares His Thoughts On MP Materials, Nokia And More In 'Lightning Round'
May 23, 2021
On CNBC's "Mad Money Lightning Round," Jim Cramer said he would pass on Opko Health Inc. (NASDAQ: OPK). BOSTON OMAHA Corp (NASDAQ: BOMN) is a hard pass, said Cramer...
Via
Benzinga
10 Health Care Stocks Showing Unusual Options Activity In Today's Session
May 14, 2021
This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges...
Via
Benzinga
Opko Health (OPK) Q1 2021 Earnings Call Transcript
April 28, 2021
OPK earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
OPKO Health: Q1 Earnings Insights
April 28, 2021
Shares of OPKO Health (NASDAQ:OPK) rose in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 155.56% over the past year to $0....
Via
Benzinga
The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping
April 28, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) Aldeyra Therapeutics, Inc...
Via
Benzinga
Exposures
Product Safety
Earnings Scheduled For April 28, 2021
April 28, 2021
Companies Reporting Before The Bell • M/I Homes (NYSE:MHO) is likely to report quarterly earnings at $1.51 per share on revenue of $758.77 million. • Melco...
Via
Benzinga
The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx
April 24, 2021
Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & Johnson (NYSE: JNJ) and Roche Holding AG (OTC:...
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.